Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Kalaris Therapeutics Inc. (KLRS) had Cash Flow from Financial Activities of $-1.70M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.86M |
|
-- |
|
-- |
|
$11.83M |
|
$-11.83M |
|
$0.98M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-10.86M |
|
$-11.83M |
|
$-12.04M |
|
23.72M |
|
23.72M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$98.47M |
|
-- |
|
$11.34M |
|
$109.81M |
|
$8.08M |
|
-- |
|
$33.17M |
|
$41.25M |
|
$68.56M |
|
$68.56M |
|
$68.56M |
|
22.99M |
|
| Cash Flow Statement Financials | |
$-11.58M |
|
$-50.35M |
|
|
Cash Flow from Financial Activities |
$-1.70M |
$98.55M |
|
$34.93M |
|
$-63.63M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.84% |
|
-15.84% |
|
-9.89% |
|
-15.84% |
|
$2.98 |
|
$-0.49 |
|
$-0.49 |
|